• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

FDA’s Approves Remdesivir to Treat Young Children With Covid-19

May 5, 2022 by Talkherald Leave a Comment

Remdesivir injection is used to treat coronavirus disease 2019 (COVID-19) in hospitalized patients. It is also used to treat mild to moderate COVID-19 in non-hospitalized patients who are at high risk for progression to severe COVID-19 (e.g., hospitalization, death). Remdesivir is an antiviral medicine that works on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Today the U.S. Food and Drug Administration approved for Covid-19 drug remdesivir to treat infants and children for 28 days. The Agency said that the FDA’s decision makes the drug first approved Covid-19 treatment for children under 12. Previously remdesivir was approved to treat Covid-19 for adults only. The drug made by Gilead Sciences and sold as remdesivir had been approved to treat adults and patients 12 and older who weighed at least 88 pounds. It is given as an injection.

Dr. Patrizia Cavazzoni, M.D., Director of FDA’s Center for Drug Evaluation and Research, said in a news release, “As Covid 19 can lead to severe illness in kids, a some of whom do not presently have vaccination option, there continues to be a need for secure and effective Covid-19 treatment options for this population. “Today’s approval of the first COVID-19 therapeutic for this population demonstrates the agency’s responsibility to that need.”
Dr. Daniel Griffin is an instructor in clinical medicine and associate research scientist in the Biochemistry and Molecular Biophysics department at Columbia University. He said The FDA’s approval of remdesivir for young children is “great.” Griffen called remdesivir a “very effective antiviral” at preventing the progression of Covis-19 to a more severe illness, lowering the risk of hospitalization or death when given early in the course of Covid-19 infection.

More recently, the results have come out truly remarkable research published in the New England Journal of Medicine showing that taking remdesivir in the first five days of the acute viral phase, before the door closes, can prevent progression by about 90%. In that study, it was 87 percent. So, if you give it to the right patient at the right time, remdesivir can be an extremely successful antiviral,” Griffin said Monday. Suppose we can expand this to youngsters and deliver it to them at the vital moment when it can make the most difference. In that case, we are opening up many possibilities because these kids don’t have a lot of options,’ he added. “They don’t have access to some of the other therapies that are only available to people over the age of 12.”

Remdesivir is an adenosine analog nucleotide prodrug. It binds to the viral RNA polymerase and prevents viral replication by prematurely stopping RNA transcription. Remdesivir has been shown to be effective against SARS-CoV-2 in vitro. 1 Remdesivir treatment was started immediately after inoculation in a rhesus macaque model of SARS-CoV-2 infection; the remdesivir-treated animals had lower viral levels in the lungs and minor lung damage than the control animals. 2 Remdesivir is predicted to be effective against the B.1.1.529 (Omicron) strain under investigation.

Talkherald
Talkherald

Related posts:

  1. A CDC Report Shows HPV Vaccine Might Be Able To Protect Unvaccinated Young Women
  2. Two Standard Food Dyes Might Be Responsible For Causing Symptoms Of Inflammatory Bowel Disease
  3. Health Experts Advise Women To Undergo Genetic Testing For Breast Cancer To Identify A Lesser Known Mutation
  4. Medical Regulators In The UK Extend COVID19 Booster Rollout Program To Individuals Over 40 Years Of Age

Filed Under: Health

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Four Radioactive Wasp Nests Have Been Found At A Nuclear Facility In South Carolina
  • Ancient Burial Practices
  • Why Do Arms And Legs “Fall Asleep”?
  • Anatoli Bugorski: The Man Who Put His Head In A Particle Accelerator And Survived
  • Alpha Centauri A – Our Closest Sun-Like Star – Has A New “Very Strong Candidate” Planet
  • Redditors Claim They Can Smell When Someone Is Pregnant. Is That Really A Thing?
  • New Monster Black Hole 36.3 Billion Times Our Sun May Be “Most Massive” Ever Found
  • An Interstellar Mission To Visit A Black Hole Might Only Take 70 Years, Astrophysicist Says
  • Four Super Rare Barbary Lion Cubs Born At Czech Zoo In Conservation Win
  • NASA’s Perseverance Snaps One Of Sharpest 360° Panoramas On Mars Ever Taken
  • UAP Researchers Search For “Transient Events” In Earth’s Shadow, Finding Unexplained Events
  • Neolithic Cannibals In Spain Ate Their Enemies As A Form Of “Ultimate Elimination”
  • RFK Jr Pulls Millions Of Dollars Of mRNA Vaccine Funding, Citing Misinformation – Here’s What To Know
  • Ride On Board A Red-Footed Booby As It Catches Flying Fish Above The Indian Ocean
  • People Returned To Live In Post-Apocalyptic Pompeii – But Life Was Never The Same
  • Keep An Eye Out For Aurorae This Week – This “Weak” Solar Flare Might Pack A Surprising Punch
  • Are You More Likely To Be Killed By An Elephant Or An Asteroid? Science Now Has The Answer
  • Five Times A Tumor Behaved Downright Weird
  • Apple Snails Can Regrow Their Eyes. Now, Scientists Are Asking: Could We?
  • Why On Earth Did Such Strange Animals Evolve On Madagascar?
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version